0001750159-24-000001.txt : 20240923 0001750159-24-000001.hdr.sgml : 20240923 20240923125841 ACCESSION NUMBER: 0001750159-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240923 DATE AS OF CHANGE: 20240923 EFFECTIVENESS DATE: 20240923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genome Medical Holding Co CENTRAL INDEX KEY: 0001750159 ORGANIZATION NAME: IRS NUMBER: 813033508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-524677 FILM NUMBER: 241315671 BUSINESS ADDRESS: STREET 1: 95 THIRD STREET, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 877.688.0992 MAIL ADDRESS: STREET 1: 95 THIRD STREET, SUITE 214 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001750159 Genome Medical Holding Co 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 877-688-0992 DELAWARE Genome Medical, Inc. None Corporation true Jill Davies c/o Genome Medical Holding Company 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Alex Parker c/o Genome Medical Holding Company 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Shaun Rodriguez c/o Genome Medical Holding Company 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Russell Glass c/o Genome Medical Holding Company 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Director Mark Sylvester c/o Genome Medical Holding Company 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Executive Officer Elizabeth Moreno c/o Genome Medical Holding Company 701 Gateway Blvd. Suite 380 South San Francisco CA CALIFORNIA 94080 Executive Officer Other Health Care Decline to Disclose 06b false 2024-09-10 false true false 0 75344304 75344304 0 Series AA Senior Preferred Stock, Series A-1 Senior Preferred Stock, Series B Senior Preferred Stock, Series C Senior Preferred Stock, Series D Senior Preferred Stock and the Common Stock issuable upon conversion thereof. false 14 0 0 0 false Genome Medical Holding Co /s/Jill Davies Jill Davies Chief Executive Officer 2024-09-23